Stem Cell Proprioceptor Differentiation Protocol
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods lack a protocol for in vitro differentiation of proprioceptors from human stem cells, which are essential for cell-based treatments and drug discovery in neurodegenerative disorders.
Innovation Solution
An in vitro method involving the use of TGFβ inhibitors and Wnt activators to differentiate stem cells into proprioceptors, with specific timing and concentration protocols to achieve high expression of proprioceptor markers, while minimizing expression of other sensory neuron markers.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If stem cells are differentiated using conventional protocols, then general sensory neuron differentiation is achieved, but proprioceptor-specific differentiation is not possible
Solution Approach 1:
The patent applies parameter changes by modifying signaling pathway parameters (TGFβ/Activin-Nodal inhibition timing and Wnt activation timing) to achieve proprioceptor-specific differentiation. The protocol specifies precise temporal parameters: TGFβ/Activin-Nodal signaling is inhibited from day 0 to day 1, followed by Wnt activation from day 2 to day 12, with specific concentration ranges (TGFβ inhibitor: 1-10 μM; Wnt activator: 0.1-2.5 μM). These parameter adjustments enable the stem cells to differentiate into proprioceptors with high marker expression (Runx3, TrkC, CDHL1) while minimizing other sensory neuron types.
2Ease of operation
If differentiation protocol is simplified, then ease of operation is improved, but manufacturing precision of proprioceptor markers is reduced
Solution Approach 1:
The patent segments the differentiation process into distinct temporal phases: Phase 1 (day 0-1) involves TGFβ/Activin-Nodal signaling inhibition to establish neural crest lineage; Phase 2 (day 2-12) involves Wnt signaling activation to specify proprioceptor fate. This segmentation allows each phase to be optimized independently, with specific concentration ranges and durations, achieving high marker expression while maintaining operational clarity through structured protocol design.
3Reliability
If differentiation time is extended, then cell maturation is improved, but productivity is reduced
Solution Approach 1:
The patent implements continuous useful action by maintaining stem cells in a defined state through continuous TGFβ/Activin-Nodal inhibition during day 0-1, followed by continuous Wnt activation during day 2-12. This uninterrupted signaling control ensures consistent progression through differentiation stages, achieving reliable maturation (high Runx3, TrkC, CDHL1 expression) while optimizing the 12-day timeline for efficient productivity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method effectively differentiates stem cells into a population with high proprioceptor marker expression, providing a valuable tool for treating proprioceptor-related disorders and neurodegenerative diseases like Friedreich's Ataxia and Parkinson's disease.
Implementation Method 1
contacting a population of stem cells with an effective amount(s) of one or more inhibitor of transforming growth factor beta (TGFβ)/Activin-Nodal signaling ('TGFβ inhibitor')
Implementation Method 2
contacting the cells with one or more activator of wingless (Wnt) signaling ('Wnt activator')
Data Source
AI summary
The presently disclosed subject matter provides for in vitro methods of inducing differentiation of stem cells (e.g., human stem cells) into proprioceptors, proprioceptors generated by such methods, and compositions comprising such proprioceptors. The presently disclosed subject matter also provides for uses of such proprioceptors for preventing and/or treating disorders of proprioceptor neurons and/or neurodegenerative disorders (e.g., Friedreich's Ataxia).